SOLTF (Nxera Pharma Co) OCF Margin %: -24.89% (As of Mar. 2026)

What is Nxera Pharma Co OCF Margin %?

Nxera Pharma Co SOLTF 84 OCF Margin % is -24.89% as of Mar. 2026. GuruFocus rates SOLTF with a GF Score™ of 84/100 and a GF Value™ of $7.77 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 959 Biotechnology companies, Nxera Pharma Co ranks better than 59.75% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Nxera Pharma Co's Cash Flow from Operations for the three months ended in Mar. 2026 was $-10.4 Mil. Nxera Pharma Co's Revenue for the three months ended in Mar. 2026 was $41.9 Mil. Therefore, Nxera Pharma Co's OCF Margin % for the quarter that ended in Mar. 2026 was -24.89%.

As of today, Nxera Pharma Co's current OCF Yield % is -5.82%.

The historical rank and industry rank for Nxera Pharma Co's OCF Margin % or its related term are showing as below:

SOLTF' s OCF Margin % Range Over the Past 10 Years
Min: -41.31 Med: 37.72 Max: 68.02
Current: -16.64

During the past 13 years, the highest OCF Margin % of Nxera Pharma Co was 68.02%. The lowest was -41.31%. And the median was 37.72%.

SOLTF's OCF Margin % is ranked better than
59.75% of 959 companies
in the Biotechnology industry
Industry Median: -66.52 vs SOLTF: -16.64

Nxera Pharma Co OCF Margin % Related Terms

Nxera Pharma Co OCF Margin % Historical Data

* Premium members only.

The historical data trend for Nxera Pharma Co's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nxera Pharma Co OCF Margin % Chart

Nxera Pharma Co Annual Data

Trend

Mar16

Mar17

Mar18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

OCF Margin %

Get a 7-Day Free Trial

40.06

63.92

-41.31

-26.77

-9.01

Nxera Pharma Co Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
OCF Margin %	Get a 7-Day Free Trial															9.23	-2.13	-44.06	-1.61	-24.89

SOLTF vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, Nxera Pharma Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nxera Pharma Co OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nxera Pharma Co's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Nxera Pharma Co's OCF Margin % falls into.

Save Embed

84GF Score

Nxera Pharma Co Ltd SOLTF

OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Nxera Pharma Co OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Nxera Pharma Co's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin	=	Cash Flow from Operations (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-17.112	/	189.943
	=	-9.01 %

Nxera Pharma Co's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin	=	Cash Flow from Operations (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-10.423	/	41.87
	=	-24.89 %

Frequently Asked Questions Learn more about OCF Margin % →

What does a OCF Margin % of -24.89% mean?

Nxera Pharma Co (SOLTF) has a OCF Margin % of -24.89% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Nxera Pharma Co and its competitors. According to the industry distribution chart, Nxera Pharma Co ranks #386 out of 959 companies in the Biotechnology industry, placing it in the top 40.3%.

Is Nxera Pharma Co's OCF Margin % too high?

Nxera Pharma Co's current OCF Margin % is -24.89%. Based on the distribution chart, Nxera Pharma Co ranks #386 out of 959 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Nxera Pharma Co has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Nxera Pharma Co's OCF Margin % compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, Nxera Pharma Co ranks #386 out of 959 companies for OCF Margin %. This puts Nxera Pharma Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good OCF Margin % for a Biotechnology company?

A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high OCF Margin % mean?

A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Nxera Pharma Co and its competitors. Nxera Pharma Co's current OCF Margin % is -24.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Nxera Pharma Co stock overvalued right now?

Based on GuruFocus' analysis, Nxera Pharma Co (SOLTF) is currently considered Modestly Undervalued. The stock's GF Value™ is $7.77, compared to a current price of $6.37 — trading 18% below its estimated fair value. The current OCF Margin % is -24.89%. Nxera Pharma Co's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is OCF Margin % calculated?

OCF Margin % is calculated from a company's financial statements. For Nxera Pharma Co (SOLTF), the current OCF Margin % is -24.89% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nxera Pharma Co (SOLTF) Overvalued in 2026?

Based on GuruFocus' analysis, Nxera Pharma Co stock appears to be undervalued. The current stock price of $6.37 is trading 18% below its estimated GF Value™ of $7.77. GuruFocus considers Nxera Pharma Co to be Modestly Undervalued.

Key valuation signals for SOLTF:

OCF Margin %: -24.89%
GF Value™: $7.77 vs. price of $6.37 (18% below fair value)
GF Score™: 84/100 with 7 warning signs

No single metric tells the full story. See the SOLTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nxera Pharma Co Business Description

Industry Healthcare Biotechnology

Comparable Companies TSE:4592 TSE:4588 TSE:4974 TSE:2160 TSE:4587 TSE:4593 TSE:4894 TSE:219A TSE:504A TSE:7774 VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges 4565:Japan

Address Midtown East, 9-7-2 Akasaka Minato-ku, Tokyo, JPN, 107-0052

Website https://www.nxera.life

Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein Coupled Receptors (GPCRs).

84GF Score

Get the complete analysis for SOLTF

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.37

Price

$7.77

GF Value

View SOLTF Analysis

See OCF Margin % data for all stocks →